Skip to main content Back to Top
Advertisement

12/4/2019

Oxytocin Injection

Products Affected - Description

    • Oxytocin injection, Fresenius Kabi, 10 unit/mL, 1 mL vial, 25 count, NDC 63323-0012-01
    • Oxytocin injection, Fresenius Kabi, 10 unit/mL, 10 mL vial, 25 count, NDC 63323-0012-10
    • Oxytocin injection, Fresenius Kabi, 10 unit/mL, 30 mL vial, 10 count, NDC 63323-0012-30

Reason for the Shortage

    • Fresenius Kabi has oxytocin injection on shortage due to manufacturing delays.
    • Par has Pitocin available.

Available Products

    • Pitocin injection, Par Sterile Products, 10 unit/mL, 1 mL vial, 25 count, NDC 42023-0116-25
    • Pitocin injection, Par Sterile Products, 10 unit/mL, 10 mL vial, 25 count, NDC 42023-0116-02
    • Pitocin injection, Par Sterile Products, 10 unit/mL, 50 mL bulk vial, 1 count, NDC 42023-0130-06

Estimated Resupply Dates

    • Fresenius Kabi has oxytocin 1 mL, 10 mL, and 30 mL vials on back order and the company estimates a release date of early- to mid-December 2019 for the 1 mL and 10 mL vials and late-December 2019 for the 30 mL vials.

Updated

Updated December 4, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 7, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins